Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.

@article{Ramalho2002FivePO,
  title={Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.},
  author={A. Ramalho and S. Beck and M. Meyer and D. Penque and G. Cutting and M. Amaral},
  journal={American journal of respiratory cell and molecular biology},
  year={2002},
  volume={27 5},
  pages={
          619-27
        }
}
  • A. Ramalho, S. Beck, +3 authors M. Amaral
  • Published 2002
  • Biology, Medicine
  • American journal of respiratory cell and molecular biology
Estimates of the level of transcripts from the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) gene required to develop a CF phenotype range from 4-20% of normal. Due to the importance of obtaining reliable data on this issue for therapeutic strategies, we developed a novel polymerase chain reaction-based method to quantify CFTR transcripts and applied it to the analysis of nasal epithelium RNA of five patients with CF and the 3272-26A>G/F508del genotype. We calculated that 8.2… Expand
165 Citations
Functional stability of rescued delta F508 cystic fibrosis transmembrane conductance regulator in airway epithelial cells.
  • 53
Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators.
  • 33
  • PDF
The holy grail of cystic fibrosis research: pharmacological repair of the F508del-CFTR mutation.
  • 6
CFTR and Cystic Fibrosis: From Structure to Function
  • 1
What’s new in cystic fibrosis? From treating symptoms to correction of the basic defect
  • 80
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 48 REFERENCES
The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.
  • 162
...
1
2
3
4
5
...